I Holland hosts webinar to help improve tablet production skills
The free webinar investigates online training and how it can essentially optimize the tablet manufacturing process.
I Holland, manufacturers of tablet tooling for the pharmaceutical and nutraceutical markets, will be sharing their knowledge by hosting a free webinar on 10 September 2020 which will focus on how to keep tablet production staff skilled with online training.
The webinar ‘How to keep tablet production staff skilled with online training’ will look at how e-learning is an effective tool in which to keep staff proficient in all areas of tablet compaction, and ultimately lead to improved productivity and an enhanced end product.
Alex Bunting, I Holland Marketing Manager said: “Online training is really important to ensure staff improve their knowledge and can easily adapt to changing regulations, requirements and operating procedures within tablet manufacture. This is particularly essential now as we look for new remote or distanced working methods in the wake of the coronavirus."
Specifically, the free webinar investigates online training and how it can essentially optimize the tablet manufacturing process by enhancing the skills of operators, technicians, supervisors and managers.
A ‘virtual classroom’ platform can help staff to advance their understanding of key aspects in tablet compaction, but with the convenience of taking place online. This means training can happen at any time and from anywhere with the flexibility to revisit key information when required.
“E-learning provides an economical training solution which results in better performance and faster tablet production. During the free webinar, our team of experts will walk attendees through the various benefits of online training and how it can be easily established within the company,” said Bunting.
Related News
-
News AI-powered therapy offers hope for rare familial polyposis
Recursion Pharmaceuticals has announced promising results from its ongoing early- to mid-stage trial evaluating its AI-powered treatment, REC-4881, for familial adenomatous polyposis (FAP).
-
News CPHI Podcast Series: AI transforming pharma manufacturing
This episode explores how AI is revolutionising the pharmaceutical industry, from "smart factories" to seamless supply chain integration, and discuss the transformative advancements shaping the next decade.
-
News AstraZeneca invests in AI-led research agreement with China's CSPC, up to US$5.3 billion
Anglo-Swedish pharmaceutical giant AstraZeneca announced they have signed a deal with China’s CSPC Pharmaceutical Group worth up to US$5.3 billion to drive AI-led research development of therapies for chronic conditions.
-
News Google-backed start-up raises US$600 million to support AI drug discovery and design
London-based Isomorphic Labs, an AI-driven drug design and development start-up backed by Google’s AI research lab DeepMind, has raised US$600 million in its first external funding round by Thrive Capital. The funding will provide further power t... -
News How GLP-1 agonists are reshaping drug delivery innovations
GLP-1 agonist drug products like Ozempic, Wegovy, and Mounjaro have taken the healthcare industry by storm in recent years. Originally conceived as treatment for Type 2 diabetes, the weight-loss effects of these products have taken on unprecedented int... -
News 2025 Pharma Trends Outlook: Collaborative Pharma – A New Era of Supply Chains
A new year, a new Pharma Trends Outlook report! The 2025 Pharma Trends Outlook report examines key changes expected in the pharmaceutical industry for the coming year, particularly in regards to the supply chain.
-
News AI-driven drug discovery model sets new accuracy prediction benchmark
Iambic Therapeutics, an Nvidia-backed biotech based in London, have stated that their AI drug discovery model named ‘Enchant’ demonstrates the potential to reduce the time and cost associated with new drug development.
-
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma.